Shed Review 2026: Microdose, Sublingual, and Brand-Name in One Place

Shed is the most format-diverse GLP-1 telehealth program in the U.S. It ships compounded semaglutide and tirzepatide as injections, sublingual lozenges, and oral drops, plus brand-name Wegovy pill, Wegovy injectable, Zepbound, and Foundayo through a separate membership. That's 11 medications across four delivery formats, and no other provider in our reviewed set comes close. The honest verdict: Shed is the right pick if you're needle-averse, want format optionality, or want the cheapest verified all-inclusive compounded semaglutide on the market. It's a poor fit if you want insurance support, want the strongest clinical evidence base, or have been burned by billing complaints in the past.

What Shed is

Shed is a direct-to-consumer telehealth platform that prescribes GLP-1 medications for weight management. The clinical model is async-first: licensed clinicians review your intake and prescribe if appropriate, and the medication ships from a partner pharmacy. Shed's program includes a health coach, dietitian resources, and a member success manager at no extra charge.

The catalog is where Shed separates from the field. On the compounded side, Shed offers semaglutide and tirzepatide as injections, microdose injections, sublingual lozenges, and oral drops. On the brand-name side, Shed facilitates Wegovy pill, Wegovy injectable, Zepbound, and Foundayo through a $125/month Shed Membership that sits separately from the medication cost. Compounded semaglutide and tirzepatide are not FDA-approved as finished products (FDA, 2024).

A practical note before pricing. Compounded medication on Shed is all-inclusive, no membership fee. Brand-name medication requires the $125/month Shed Membership on top of the medication cost. The pricing model splits at the brand-vs-compounded line, and the distinction matters at checkout.

The multi-format catalog (the real differentiator)

Most GLP-1 telehealth providers offer two or three medications and one delivery format. Shed offers 11 medications across four formats. Walking through what each is and who it's for.

Compounded injectable (semaglutide and tirzepatide). The standard compounded GLP-1 product across the industry. Subcutaneous injection, once weekly. This is the format with the strongest evidence base because the large clinical trials that established semaglutide's weight-loss effect studied subcutaneous injection (NEJM, 2021). If you've used GLP-1s before, this is what you know.

Microdose injectable (semaglutide and tirzepatide). A lower-dose program designed for tolerability or maintenance, priced lower than full-dose compounded. Microdose semaglutide at $149/month is the cheapest verified all-inclusive compounded GLP-1 in our reviewed roster. The trade-off: at microdose, the effect on weight is likely smaller than at standard dose. This format suits patients who tolerate side effects poorly, who want to extend treatment at a lower cost, or who are using GLP-1s for goals other than maximum weight loss.

Sublingual lozenges (semaglutide). Daily dissolvable lozenges. The pitch is needle-free administration with absorption through the oral mucosa. The honest caveat: compounded sublingual formulations have not been studied in the large trials that anchored the FDA approvals for Wegovy and Zepbound. Bioavailability for sublingual semaglutide is not well-established. Whether the drug reaches therapeutic concentrations through this route is not settled.

Oral drops (semaglutide and tirzepatide). Daily sublingual oral drops. Same evidence caveats apply. Oral drops are the most expensive compounded format on Shed, which is the inverse of what most patients expect.

Brand-name (Wegovy pill, Wegovy injectable, Zepbound, Foundayo). The FDA-approved options. Foundayo is Eli Lilly's recently approved oral GLP-1 pill, and Shed is one of the few telehealth providers prescribing it. Brand-name pricing on Shed requires the $125/month Shed Membership in addition to the medication cost. Foundayo medication itself is fulfilled through LillyDirect or third-party pharmacies; the Shed Membership covers clinical care and coordination.

The needle-averse use case is the strongest argument for Shed. Patients with genuine needle anxiety, or patients who want oral or sublingual administration for lifestyle reasons, have very few options elsewhere. Most providers only stock injections (compounded or brand pen) plus the Wegovy pill and Foundayo. Shed is the only place where sublingual lozenges and oral drops are part of the catalog.

That said, talk to a licensed healthcare provider about whether a non-injection format is right for you, especially given the limited evidence base for those routes.

Shed pricing: the honest version

Prices throughout this article reflect what providers advertised as of May 2026 and may change. We verified Shed's pricing structure at intake in May 2026.

Two structures run in parallel.

Compounded medications are all-inclusive. One monthly charge covers the medication, telehealth visits, async clinician messaging, coaching, and shipping. No separate membership fee. The headline price is tied to commitment length: 12-month plans are cheapest, 6-month plans cost more per month, month-to-month is the most expensive. There's a 2-month minimum on every compounded offering.

Brand-name medications require the $125/month Shed Membership. This is the brand-name access fee, separate from the medication cost. The membership covers clinical care and program coordination for the brand-name pathway, where the medication itself is dispensed through manufacturer programs (NovoCare, LillyDirect) or third-party pharmacies.

Here is the full medication-by-format matrix on the 12-month plan, the lowest published rate for each option:

Medication	Medication price	Shed Membership	Total
Compounded semaglutide (injectable)	$175/mo	$0	$175/mo
Compounded tirzepatide (injectable)	$245/mo	$0	$245/mo
Microdose compounded semaglutide (injectable)	$149/mo	$0	$149/mo
Microdose compounded tirzepatide (injectable)	$199/mo	$0	$199/mo
Compounded semaglutide (sublingual lozenges)	$299/mo	$0	$299/mo
Compounded semaglutide (oral drops)	$329/mo	$0	$329/mo
Compounded tirzepatide (oral drops)	$419/mo	$0	$419/mo
Brand Wegovy pill (starter dose)	$149/mo	$125/mo	$274/mo
Brand Wegovy injectable pen (starter dose)	$149/mo	$125/mo	$274/mo
Brand Foundayo (starter dose)	$149/mo	$125/mo	$274/mo
Brand Zepbound (starter dose)	$299/mo	$125/mo	$424/mo

A few notes. The compounded injectable rates climb at higher commitment lengths: compounded semaglutide is $199/mo on the 6-month plan and $249/mo month-to-month. The same pattern applies to compounded tirzepatide ($279/mo on 6-month, $349/mo month-to-month). Brand-name medications escalate by dose: Wegovy pen runs $149–$349/mo by dose, Wegovy pill runs $149–$299/mo, Zepbound runs $299–$499/mo, and Foundayo escalates roughly $149 to $199 to $299 by dose tier per LillyDirect's structure.

Microdose semaglutide at $149/mo is the headline number worth pointing at. It's the cheapest all-inclusive compounded GLP-1 we've verified in the U.S. telehealth market as of May 2026. Whether the microdose program suits your goals is a separate clinical conversation, but on price alone, nothing else clears that floor.

Care model: what's included

Shed's program includes a licensed clinician, an async messaging channel, a health coach, dietitian resources, and a member success manager. The clinical model is async-first: most patients won't need a synchronous video visit to start. Side-effect monitoring, dose adjustments, and refill requests run through the messaging system.

The program structure suits patients who want a full program with coaching, but who don't need the heavy behavioral-change machinery that Found or WeightWatchers Clinic structures. If you want efficient access to medication with some coaching available when you need it, Shed delivers. If you want a structured behavior-change app with daily logging and dedicated 1:1 coaching calls, the model is lighter than that.

One real concern worth naming. Shed has a pattern of billing complaints on BBB and Consumer Affairs around cancellation and unexpected charges. Most of these involve the 2-month minimum, the upfront 12-month payment structure, and friction around stopping subscriptions. The complaints don't suggest the medication itself is the problem; they suggest the contract terms are stricter than some patients expect at signup. Read the cancellation and refund terms carefully before paying.

Compounded medication context

Compounded semaglutide and tirzepatide are not FDA-approved as finished products. The active ingredients are the same as Wegovy and Zepbound, but the finished compounded formulations have not gone through FDA approval. This applies to every Shed compounded product, including the sublingual lozenges and oral drops where the evidence base is even thinner.

The regulatory backdrop matters. The FDA declared the tirzepatide shortage resolved in October 2024 and the semaglutide shortage resolved in February 2025, with enforcement discretion ending in spring 2025 (FDA statement on compounders as GLP-1 supply stabilizes). Novo Nordisk and Eli Lilly have pursued legal action against compounding pharmacies and telehealth platforms over the past 18 months. Compounded access remains legal under specific circumstances, including documented clinical need based on dose or formulation, but the environment is less stable than it was in 2023.

For deeper context on the compounded-vs-brand decision, see our compounded vs brand-name semaglutide breakdown.

Pros and cons

Who Shed is for, and who it isn't

Shed fits if you:

• Want a non-injection compounded GLP-1 format (sublingual lozenge or oral drops) and accept the limited evidence base for those routes
• Are needle-averse but still want compounded pricing
• Want the cheapest verified all-inclusive compounded option ($149/mo Microdose semaglutide)
• Want both compounded and brand-name medication access in one program
• Are willing to commit to 12 months upfront to lock in the lowest compounded rate

Shed does not fit if you:

• Have insurance that might cover a GLP-1 and want help with prior authorization (try Found instead)
• Want only brand-name medication and don't want to wade through compounded options (try Hers)
• Need the strongest clinical evidence base and would only use an FDA-approved product
• Want month-to-month flexibility without paying a meaningful premium
• Have been burned by sticky cancellation terms in the past

Alternatives if you're shopping around

Three providers cover overlapping ground in different ways.

Found is the closest peer on catalog breadth. Found offers 10 medications including compounded semaglutide, tirzepatide, and liraglutide, plus Wegovy pill, Wegovy pen, Zepbound, and Foundayo. The structural difference: Found bills a separate CORE membership ($99–$149/mo by commitment length) on top of medication, so compounded semaglutide totals $248–$298/mo at Found versus $149–$175/mo on Shed. Found wins on insurance support (free insurance check before payment) and structured behavioral coaching. Shed wins on price for compounded and on format diversity.

Hers is the brand-name-only alternative. Hers prescribes Wegovy pill, Wegovy pen, Foundayo, Zepbound, Ozempic, and Mounjaro on a $149/month membership ($39 for the first month) through a Novo Nordisk partnership. There are no compounded options to weigh, and the pricing model is simpler. Shed's brand Wegovy pill total is $274/mo all-in versus Hers' $298/mo, so Shed is slightly cheaper on the matching SKU. Hers is the cleaner path if you only want brand catalog.

Eden is the simpler compounded-only alternative. Compounded semaglutide runs $129 for the first month and roughly $209/month ongoing on a 3-month plan, with no separate membership. Eden also facilitates brand-name Wegovy through NovoCare and brand Zepbound through LillyDirect. The trade-off: no microdose program, no sublingual or oral-drop formats, and no in-house brand-name coordination at Shed's price.

For a full price-by-dose comparison across providers, see our cheapest semaglutide online breakdown or the live GLP-1 pricing tool.

Bottom line

Shed is a legitimate program with a real differentiator: format diversity. Microdose semaglutide at $149/mo is the cheapest verified all-inclusive compounded GLP-1 we've found, and the sublingual lozenge and oral-drop options are not available anywhere else in our reviewed roster. If you're needle-averse or want format optionality, Shed is the answer to a question other providers don't address.

The honest caveats are the limited evidence base for non-injection compounded formats, the $125/mo Shed Membership on top of brand-name medication, and the billing-complaint pattern around cancellation. Read the contract terms carefully and confirm the exact price for your dose and commitment length at intake before paying.

If you want insurance support or structured behavioral coaching, Found is the closer fit. If you want brand-name-only with no compounded options to weigh, Hers is the cleaner path. If you want a simpler compounded program at a lower out-of-pocket without the format options, Eden is worth comparing.

As with any GLP-1, talk to a licensed healthcare provider before starting or switching medications. Side effect profiles, contraindications, format suitability, and dose escalation all warrant a real clinical conversation, not just a checkout flow.